Vlastimil Král

1.0k total citations
36 papers, 510 citations indexed

About

Vlastimil Král is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Organic Chemistry. According to data from OpenAlex, Vlastimil Král has authored 36 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Organic Chemistry. Recurrent topics in Vlastimil Král's work include Enzyme function and inhibition (11 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Protein purification and stability (4 papers). Vlastimil Král is often cited by papers focused on Enzyme function and inhibition (11 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Protein purification and stability (4 papers). Vlastimil Král collaborates with scholars based in Czechia, United States and Bulgaria. Vlastimil Král's co-authors include Milan Fábry, Michal Pechar, Robert Pola, Pavel Otáhal, Pavlína Řezáčová, Irena Sieglová, J. Brynda, Karel Ulbrich, Marek Trněný and Richard Laga and has published in prestigious journals such as Blood, Nanoscale and Biomacromolecules.

In The Last Decade

Vlastimil Král

34 papers receiving 503 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Vlastimil Král 213 143 124 81 70 36 510
Marcelo Fernández 224 1.1× 130 0.9× 226 1.8× 102 1.3× 187 2.7× 59 730
Yanchun Meng 298 1.4× 262 1.8× 193 1.6× 83 1.0× 50 0.7× 41 655
Sumit Majumdar 267 1.3× 72 0.5× 99 0.8× 74 0.9× 40 0.6× 16 428
Khalid Abu Ajaj 222 1.0× 163 1.1× 97 0.8× 88 1.1× 76 1.1× 16 497
Céline Nicolazzi 366 1.7× 133 0.9× 83 0.7× 50 0.6× 29 0.4× 28 564
Zhaozhong Han 434 2.0× 62 0.4× 185 1.5× 116 1.4× 56 0.8× 23 610
Akihisa Otaka 356 1.7× 89 0.6× 56 0.5× 83 1.0× 143 2.0× 42 695
Timothy M. Jacobs 505 2.4× 92 0.6× 127 1.0× 112 1.4× 35 0.5× 28 812
Christopher R. Behrens 294 1.4× 206 1.4× 240 1.9× 33 0.4× 76 1.1× 12 615
Rajesh Shinde 371 1.7× 227 1.6× 51 0.4× 169 2.1× 74 1.1× 35 736

Countries citing papers authored by Vlastimil Král

Since Specialization
Citations

This map shows the geographic impact of Vlastimil Král's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vlastimil Král with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vlastimil Král more than expected).

Fields of papers citing papers by Vlastimil Král

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vlastimil Král. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vlastimil Král. The network helps show where Vlastimil Král may publish in the future.

Co-authorship network of co-authors of Vlastimil Král

This figure shows the co-authorship network connecting the top 25 collaborators of Vlastimil Král. A scholar is included among the top collaborators of Vlastimil Král based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vlastimil Král. Vlastimil Král is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kugler, Michaël, Jan Nekvinda, Josef Holub, et al.. (2021). Inhibitors of CA IX Enzyme Based on Polyhedral Boron Compounds. ChemBioChem. 22(18). 2741–2761. 28 indexed citations
2.
Kugler, Michaël, Josef Holub, J. Brynda, et al.. (2020). The structural basis for the selectivity of sulfonamido dicarbaboranes toward cancer-associated carbonic anhydrase IX. Journal of Enzyme Inhibition and Medicinal Chemistry. 35(1). 1800–1810. 12 indexed citations
3.
Grüner, Bohumı́r, Michaël Kugler, Josef Holub, et al.. (2020). Cobalt Bis(dicarbollide) Alkylsulfonamides: Potent and Highly Selective Inhibitors of Tumor Specific Carbonic Anhydrase IX. ChemPlusChem. 86(3). 351–351. 4 indexed citations
4.
Kašpar, Ondřej, Vlastimil Král, Michal Pechar, et al.. (2020). Functionalized hydrogel microparticles prepared by microfluidics and their interaction with tumour marker carbonic anhydrase IX. Soft Matter. 16(37). 8702–8709. 6 indexed citations
5.
Tykvart, Jan, Václav Navrátil, Michaël Kugler, et al.. (2020). Identification of Novel Carbonic Anhydrase IX Inhibitors Using High-Throughput Screening of Pooled Compound Libraries by DNA-Linked Inhibitor Antibody Assay (DIANA). SLAS DISCOVERY. 25(9). 1026–1037. 8 indexed citations
6.
Kugler, Michaël, Josef Holub, Václav Šícha, et al.. (2020). Sulfonamido carboranes as highly selective inhibitors of cancer-specific carbonic anhydrase IX. European Journal of Medicinal Chemistry. 200. 112460–112460. 29 indexed citations
7.
Šácha, Pavel, Libor Kostka, Jiří Schimer, et al.. (2019). Inhibitor–Polymer Conjugates as a Versatile Tool for Detection and Visualization of Cancer-Associated Carbonic Anhydrase Isoforms. ACS Omega. 4(4). 6746–6756. 13 indexed citations
8.
Ráliš, Jan, Irena Sieglová, Vlastimil Král, et al.. (2018). Radiolabeling of the antibody IgG M75 for epitope of human carbonic anhydrase IX by 61Cu and 64Cu and its biological testing. Applied Radiation and Isotopes. 143. 87–97. 9 indexed citations
9.
10.
Král, Vlastimil, et al.. (2018). Antibody-pHPMA functionalised fluorescent silica nanoparticles for colorectal carcinoma targeting. RSC Advances. 8(39). 21679–21689. 4 indexed citations
11.
Ráliš, Jan, et al.. (2017). In vitro evaluation of the monoclonal antibody 64Cu-IgG M75 against human carbonic anhydrase IX and its in vivo imaging. Applied Radiation and Isotopes. 133. 9–13. 10 indexed citations
12.
Škerlová, Jana, Vlastimil Král, Michael Kachala, et al.. (2015). Molecular mechanism for the action of the anti-CD44 monoclonal antibody MEM-85. Journal of Structural Biology. 191(2). 214–223. 12 indexed citations
13.
Škerlová, Jana, Vlastimil Král, Milan Fábry, et al.. (2014). Optimization of the crystallizability of a single-chain antibody fragment. Acta Crystallographica Section F Structural Biology Communications. 70(12). 1701–1706. 1 indexed citations
14.
Tokárová, Viola, et al.. (2013). Feasibility and constraints of particle targeting using the antigen–antibody interaction. Nanoscale. 5(23). 11490–11490. 11 indexed citations
15.
Lochman, I, et al.. (2010). ANCA in the diagnosis of neutrophil-mediated inflammation. Autoimmunity Reviews. 10(6). 295–298. 23 indexed citations
16.
Skorkovský, Jiří, et al.. (2009). Serological response to tick-borne encephalitis (TBE) vaccination in the elderly – results from an observational study. Expert Opinion on Biological Therapy. 9(7). 797–803. 35 indexed citations
17.
Král, Vlastimil, Irena Sieglová, J. Brynda, et al.. (2008). Potent inhibition of drug-resistant HIV protease variants by monoclonal antibodies. Antiviral Research. 78(3). 275–277. 6 indexed citations
18.
Král, Vlastimil, P. Mäder, Renata Collard, et al.. (2007). Stabilization of antibody structure upon association to a human carbonic anhydrase IX epitope studied by X‐ray crystallography, microcalorimetry, and molecular dynamics simulations. Proteins Structure Function and Bioinformatics. 71(3). 1275–1287. 27 indexed citations
19.
Švecová, Helena, et al.. (2007). Radioiodination of mouse anti-III β-tubulin antibodies and their evaluation with respect to their use as diagnostic agents for peripheral neuropathies. Applied Radiation and Isotopes. 66(3). 310–316. 1 indexed citations
20.
Král, Vlastimil, et al.. (1991). [What is next in antirabies immunization?].. PubMed. 130(2). 54–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcelo Fernández Breakdown of academic impact, for papers by Yanchun Meng Breakdown of academic impact, for papers by Sumit Majumdar Breakdown of academic impact, for papers by Khalid Abu Ajaj Breakdown of academic impact, for papers by Céline Nicolazzi Breakdown of academic impact, for papers by Zhaozhong Han Breakdown of academic impact, for papers by Akihisa Otaka Breakdown of academic impact, for papers by Timothy M. Jacobs Breakdown of academic impact, for papers by Christopher R. Behrens Breakdown of academic impact, for papers by Rajesh Shinde
Rankless by CCL
2026